BIOGEN INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 215.5 USD | +3.16% |
|
+11.02% | -16.72% |
| Apr. 29 | Wall Street: buoyed by Tesla, confident ahead of FOMC meeting | CF |
| Apr. 26 | Guggenheim Adjusts Price Target on Biogen to $255 From $275 | MT |
ETFs positioned on Biogen Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.10% | 194 M€ | +7.48% | - | |
| 0.10% | 441 M€ | +9.86% | ||
| 0.10% | 35 M€ | +10.02% | - | |
| 0.09% | 322 M€ | +13.88% | - | |
| 0.09% | 29 M€ | -.--% | - | |
| 0.09% | 1 M€ | -.--% | ||
| 0.08% | 1,006 M€ | -.--% | - | |
| 0.08% | 414 M€ | +9.79% | - | |
| 0.08% | 2,658 M€ | +10.32% | - | |
| 0.08% | 14 M€ | +16.19% | - | |
| 0.07% | 0 M€ | 0.00% | - | |
| 0.07% | 786 M€ | -.--% | ||
| 0.07% | 23 M€ | -.--% | - | |
| 0.07% | 607 M€ | +0.05% | - | |
| 0.07% | 1,166 M€ | +0.26% | - | |
| 0.07% | 10 M€ | +6.26% | ||
| 0.07% | 617 M€ | +4.77% | - | |
| 0.07% | 9 M€ | +6.62% | - | |
| 0.06% | 273 M€ | +16.88% | ||
| 0.06% | 34 M€ | +6.71% | - | |
| 0.06% | 206 M€ | -.--% | ||
| 0.06% | 389 M€ | +6.76% | - | |
| 0.06% | 284 M€ | -.--% | ||
| 0.05% | 302 M€ | +4.32% | - | |
| 0.05% | 39 M€ | +4.26% | - | |
| 0.04% | 805 M€ | -1.35% | - |
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
Pharmaceuticals
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
215.5
USD
Average target price
286
USD
Spread / Average Target
+32.70%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -16.72% | 31.38B | |
| -3.52% | 87.17B | |
| +1.97% | 40.1B | |
| +56.59% | 25.12B | |
| -14.82% | 15.59B | |
| -8.82% | 12B | |
| -16.29% | 11.8B | |
| -41.58% | 11.8B | |
| +6.14% | 8.81B | |
| -9.59% | 8.24B |
- Stock Market
- Equities
- BIIB Stock
- Funds and ETFs Biogen Inc.
